Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
goserelin acetate
- Development stage
- Approved
- Lead developer
- CSPC Pharmaceutical Group
- Modality
- Peptides
- Administration
- Subcutaneous
01
Overview
SYH9016 is an extended-release injectable formulation of goserelin acetate, a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH). Developed by Beijing Kangchuanglian Biopharmaceutical (a subsidiary or partner of CSPC Pharmaceutical Group), SYH9016 acts as a GnRH receptor agonist. Upon administration, it induces a transient increase in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), followed by the downregulation of GnRH receptors in the pituitary gland. This results in the suppression of gonadotropin secretion and a subsequent fall in serum testosterone levels to castrate levels, which inhibits the growth of hormone-dependent prostate cancer. As an extended-release injection, SYH9016 aims to provide a more convenient or optimized delivery compared to traditional goserelin implants.
- Other names
- Goserelin Acetate Extended-Release InjectionSYH9016 InjectionSYH-9016 InjectionSYH 9016 Injection
02
Targets
GnRHR (Gonadotropin-releasing hormone receptor)
Beyond the preview
Go deeper on goserelin acetate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on goserelin acetate.